Dr. Lisa B. Kole

Partner

lisa.kole@bakerbotts.com

New York

P: +1.212.408.2628 F: +1.212.259.2428
Lisa Kole Photo

Lisa Kole is a medical doctor and Ph.D. scientist who has extensive experience in intellectual property law in the life sciences. Her areas of focus include assessment of patents for investment value and building portfolios through patent prosecution and licensing. Dr. Kole also engages in pre-litigation assessments and in patent-related litigation, including ANDA litigation. She has worked in the areas of antibodies, cytokines, and other biologics, small molecule antiinflammatories and other pharmaceuticals, viruses and anti-viral therapies and vaccines, cancer and related treatments, and drug delivery technology. Her clients include pharmaceutical companies, investment and venture firms and universities.

Dr. Kole holds a bachelor’s degree in chemistry from Cornell University and a doctoral degree in Cellular and Molecular Biology from The Rockefeller University. She is also a licensed medical doctor, and during her residency specialized in neurology. She has been a partner at Baker Botts since 1999.

Related Experience

  • Large Pharmaceutical Company – counseling regarding intellectual property strategies for protecting biologics; counseling regarding patent portfolios of acquisition targets involving small and large molecules; prosecution and strategy relating to antibody technology
  • Columbia University – patent prosecution and portfolio management
  • Ethypharm – counseling in patent matters, Orange Book related issues, and ANDA litigation (e.g., Ethypharm and Takeda v. Mylan Inc.)
  • Novo Nordisk – counseling regarding licensing and prosecution strategy; litigation support and due diligence reviews
  • University of Pittsburgh – counseling in patent matters, patent procurement
  • Investment Company – advice regarding patent portfolios covering investment targets; modeling timeline of patent coverage and potential challenges

Awards & Community

Recognized as a New York Super Lawyer, 2016

Recognized for transactions and prosecution in the Intellectual Asset Managment IAM Patent 1000, 2016

Recommended in The Legal 500 U.S., 2013

News

Publications, Speeches & Presentations

Patent Law Evolving to Meet Bioinformatics: Genomics Revolution Has Spawned Innumerable Patentable Inventions, but Pitfalls Exist

External Articles